UK fines companies for hiking epilepsy drug price 2,600 pct

LONDON (AP) — British regulators have fined U.S. drugmaker Pfizer and distributor Flynn Pharma almost 90 million pounds ($114.6 million) for increasing the cost of an epilepsy drug by as much as 2,600 percent.